Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils

Journal of Immunology

Volumn 170, Issue 7, 2003, Pages 3883-3889

  De Vries, Bart ^a   Köhl, Jörg ^c   Leclercq, Wouter K G ^a   Wolfs, Tim G A M ^a   van Bijnen, Annemarie A J H M ^a   Heeringa, Peter ^b   Buurman, Wim A ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR ANTAGONIST; COMPLEMENT INHIBITOR; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; INFLAMMATION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE; MALE; MESANGIUM CELL; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; UPREGULATION;

EID: 0347997275     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.7.3883     Document Type: Article

References (41)

1. Thadhani, R., M. Pascual, and J. V. Bonventre. 1996. Acute renal failure. N. Engl. J. Med. 334:1448.
2. Heinzelmann, M., J. M. Mercer, and J. C. Passmore. 1999. Neutrophils and renal failure. Am. J. Kidney Dis. 34:384.
3. Miura, M., X. Fu, Q. W. Zhang, D. G. Remick, and R. L. Fairchild. 2001. Neutralization of groalpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am. J. Pathol. 159:2137.
4. Lukacs, N. W., C. Hogaboam, E. Campbell, and S. L. Kunkel. 1999. Chemokines: function, regulation and alteration of inflammatory responses. Chem. Immunol. 72:102.
5. Zhou, W., C. A. Farrar, K. Abe, J. R. Pratt, J. E. Marsh, Y. Wang, G. L. Stahl, and S. H. Sacks. 2000. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 105:1363.
6. Vakeva, A. P., A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl. 1998. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97:2259.
7. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. Marsh Jr., G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146.
8. Kilgore, K. S., P. A. Ward, and J. S. Warren. 1998. Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of Pselectin and platelet activating factor. Inflammation 22:583.
9. Kilgore, K. S., C. M. Flory, B. F. Miller, V. M. Evans, and J. S. Warren. 1996. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am. J. Pathol. 149:953.
10. Cragg, M. S., W. J. Howatt, L. Bloodworth, V. A. Anderson, B. P. Morgan, and M. J. Glennie. 2000. Complement mediated cell death is associated with DNA fragmentation. Cell Death Differ. 7:48.
11. Gerard, C., and N. P. Gerard. 1994. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775.
12. Czermak, B. J., V. Sarma, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. In vitro and in vivo dependency of chemokine generation on C5a and TNF-α. J. Immunol. 162:2321.
13. Schieferdecker, H. L., G. Schlaf, K. Jungermann, and O. Gotze. 2001. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. Int. Immunopharmacol. 1:469.
14. Guo, R. F., M. Huber-Lang, X. Wang, V. Sarma, V. A. Padgaonkar, R. A. Craig, N. C. Riedemann, S. D. McClintock, T. Hlaing, M. M. Shi, and P. A. Ward. 2000. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J. Clin. Invest. 106:1271.
15. Mukherjee, P., and G. M. Pasinetti. 2001. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J. Neurochem. 77:43.
16. De Vries, B., R. A. Matthijsen, T. G. Wolfs, A. A. Van Bijnen, P. Heeringa, and W. Buurman. 2003. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 75:375.
17. Riley, R. D., H. Sato, Z. Q. Zhao, V. H. Thourani, J. E. Jordan, A. X. Fernandez, X. L. Ma, D. R. Hite, D. F. Rigel, T. C. Pellas, et al. 2000. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization. J. Thorac. Cardiovasc. Surg. 120:350.
18. Amsterdam, E. A., G. L. Stahl, H. L. Pan, S. V. Rendig, M. P. Fletcher, and J. C. Longhurst. 1995. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am. J. Physiol. 268:H448.
19. Arumugam, T. V., I. A. Shiels, T. M. Woodruff, R. C. Reid, D. P. Fairlie, and S. M. Taylor. 2002. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J. Surg. Res. 103:260.
20. Heller, T., M. Hennecke, U. Baumann, J. E. Gessner, A. M. zu Vilsendorf, M. Baensch, F. Boulay, A. Kola, A. Klos, W. Bautsch, and J. Kohl. 1999. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163:985.
21. + Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165:2628.
22. Jordan, J. E., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of mannosebinding lectin reduces postischemic myocardial reperfusion injury. Circulation 104:1413.
23. Buerke, M., H. Schwertz, W. Seitz, J. Meyer, and H. Darius. 2001. Novel small molecule inhibitor of cls exerts cardioprotective effects in ischemia-reperfusion injury in rabbits. J. Immunol. 167:5375.
24. Baumann, U., J. Kohl, T. Tschernig, K. Schwerter-Strumpf, J. S. Verbeek, R. E. Schmidt, and J. E. Gessner. 2000. A codominant role of FcγRI/III and C5aR in the reverse Arthus reaction. J. Immunol. 164:1065.
25. Burne, M. J., M. Haq, H. Matsuse, S. Mohapatra, and H. Rabb. 2000. Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model. Transplantation 69:1023.
26. Park, P., M. Haas, P. N. Cunningham, J. J. Alexander, L. Bao, J. M. Guthridge, D. M. Kraus, V. M. Holers, and R. J. Quigg. 2001. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. J. Am. Soc. Nephrol. 12:1383.
27. Iwata, A., J. M. Harlan, N. B. Vedder, and R. K. Winn. 2002. The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials. Blood 100:2077.
28. Daemen, M. A., C. van't Veer, G. Denecker, V. H. Heemskerk, T. G. Wolfs, M. Clauss, P. Vandenabeele, and W. A. Buurman. 1999. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J. Clin. Invest. 104:541.
29. Amsterdam, E. A., S. V. Rendig, and J. C. Longhurst. 1992. Contractile actions of C5a on isolated porcine myocardium. Am. J. Physiol. 263:H740.
30. Zwirner, J., A. Fayyazi, and O. Gotze. 1999. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol. Immunol. 36:877.
31. Zahedi, R., M. Braun, R. A. Wetsel, B. H. Ault, A. Khan, T. R. Welch, M. Frenzke, and A. E. Davis. 2000. The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin. Exp. Immunol. 121:226.
32. Abe, K., M. Miyazaki, T. Koji, A. Furusu, T. Nakamura-Kurashige, T. Nishino, Y. Ozono, T. Harada, H. Sakai, and S. Kohno. 2001. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int. 60:137.
33. Pellas, T. C., W. Boyar, J. van Oostrum, J. Wasvary, L. R. Fryer, G. Pastor, M. Sills, A. Braunwalder, D. R. Yarwood, R. Kramer, et al. 1998. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. J. Immunol. 160:5616.
34. Jordan, J. E., Z. Q. Zhao, and J. Vinten-Johansen. 1999. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43:860.
35. Paller, M. S. 1989. Effect of neutrophil depletion on ischemic renal injury in the rat. J. Lab. Clin. Med. 113:379.
36. Thornton, M. A., R. Winn, C. E. Alpers, and R. A. Zager. 1989. An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am. J. Pathol. 135:509.
37. Daemen, M. A., B. de Vries, C. van't Veer, T. G. Wolfs, and W. A. Buurman. 2001. Apoptosis and chemokine induction after renal ischemia-reperfusion. Transplantation 71:1007.
38. Lentsch, A. B., H. Yoshidome, W. G. Cheadle, F. N. Miller, and M. J. Edwards. 1998. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protien-2 and KC. Hepatology 27:1172.
39. Czermak, B. J., A. B. Lentsch, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement. Am. J. Pathol. 154:1513.
40. Sato, T., M. G. Van Dixhoorn, F. A. Prins, A. Mooney, N. Verhagen, Y. Muizert, J. Savill, L. A. Van Es, and M. R. Daha. 1999. The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis. J. Am. Soc. Nephrol. 10:1242.
41. Hughes, J., M. Nangaku, C. E. Alpers, S. J. Shankland, W. G. Couser, and R. J. Johnson. 2000. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am. J. Physiol. 278:F747.